marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q3
added 11-09-2023
NeuBase Therapeutics Cash Flow 2011-2024 | NBSE
Annual Cash Flow NeuBase Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-29 M | -18.9 M | -10.7 M | -2.85 M | -9.49 M | -19.3 M | -16 M | - | -5.36 M | -2.69 M | -1.75 M | -1 M |
Depreciation & Amortization |
800 K | 400 K | 280 K | 128 K | 1.12 M | 1.17 M | 1.19 M | 1.18 M | 466 K | 91.1 K | 9.46 K | 5 K |
Accounts Payables |
1.84 M | 1.81 M | 1.51 M | 1.48 M | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow NeuBase Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -3.45 M | -5.69 M | -22.4 M | - | -8.19 M | -5.27 M | -13.4 M | -7.3 M | - | -3.78 M | -7.14 M | -4.26 M | -3.78 M | -2.44 M | -395 K | -259 K | -2.44 M | -14.9 K | -8.9 M | -7.71 M | -567 K | -4.2 M | -14 M | -9.9 M | -4.2 M | -5.93 M | - | - | - | - | - | - | - | -2.74 M | - | -1.84 M | - | -1.29 M | -1.77 M | -1.04 M | -1.29 M | -661 K | -1.23 M | -809 K | -661 K | -224 K | -596 K | -366 K | -224 K |
Depreciation & Amortization |
100 K | 200 K | 187 K | 199 K | 200 K | 200 K | 191 K | 181 K | 252 K | 100 K | 80 K | 68.1 K | 231 K | 200 K | 68.1 K | 150 K | 8.82 K | 166 K | 150 K | - | 843 K | 279 K | 167 K | 285 K | 879 K | 289 K | 285 K | 298 K | 890 K | 296 K | 298 K | 298 K | 884 K | 283 K | 298 K | 306 K | 161 K | 116 K | 22.1 K | 2.92 K | 7.09 K | 4.73 K | 2.92 K | 2.36 K | 7.09 K | 4.73 K | 2.36 K | 2.36 K | 3.75 K | 2.5 K | 2.36 K |
Accounts Payables |
259 K | 322 K | 590 K | 370 K | 1.84 M | 1.66 M | 1.62 M | 1.19 M | 1.81 M | 1.52 M | 1.81 M | 1.18 M | 1.51 M | 1.51 M | 1.51 M | 1.37 M | 1.48 M | 1.48 M | 1.48 M | 165 K | 21.7 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | 150 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 28.5 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency